Cardiac Science Named Orange County's Fastest Growing Technology Company in Deloitte Technology Fast 50 Program IRVINE, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public access defibrillators (AEDs), has been named the winner of Deloitte's prestigious Technology Fast 50 Program for Orange County, a ranking of the 50 fastest growing technology companies in the area by Deloitte & Touche LLP, one of the nation's leading professional services firms. Rankings are based on the percentage of growth in fiscal year revenue over five years, from 1999-2003. Cardiac Science's increase in revenue of more than 60 thousand percent from 1999 to 2003 resulted in a number one ranking in the Fast 50 for Orange County. Cardiac Science's Chairman & CEO Raymond W. Cohen credits the dedication and creativity of the Cardiac Science employees as well as the strategic decision to enter the public access AED market as the primary drivers behind the company's revenue growth over the five-year period. Cohen said, "Our decision to begin selling AEDs in 2001 gave us access to an exciting and emerging market. That market, which includes businesses, schools, fire, police, military, public buildings, and many other places where people meet and gather, has continued to grow in the U.S. and abroad and we expect that market growth to continue as legislators and the general public call for more ready access to these lifesaving devices. To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 1999 and $1,000,000 in 2003, be headquartered in North America, and be a "technology company" defined as owning proprietary technology that contributes to a significant portion of the company's operating revenues (using other companies' technology in a unique way does not qualify); and/or devoting a significant proportion of revenues to research and development of technology. Winners of the 19 regional Technology Fast 50 programs in the United States and Canada are automatically entered in the Deloitte Technology Fast 500 program, which ranks North America's top 500 fastest growing technology companies. For more information on the Fast 50 or Fast 500 programs, visit http://www.fast500.com/. About Cardiac Science Cardiac Science develops, manufactures and markets Powerheart(R)-brand public-access defibrillators (AEDs) and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The Company also makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies. For more information, please visit http://www.cardiacscience.com/, email Cardiac Science at or call 1-949-797-3800. About Deloitte Deloitte, one of the nation's leading professional services firms, provides audit, tax, financial advisory services and consulting through nearly 30,000 people in more than 80 U.S. cities. Known as an employer of choice for innovative human resources programs, the firm is dedicated to helping its clients and its people excel. "Deloitte" refers to the associated partnerships of Deloitte & Touche USA LLP (Deloitte & Touche LLP and Deloitte Consulting LLP) and subsidiaries. Deloitte is the US member firm of Deloitte Touche Tohmatsu. For more information, please visit Deloitte's web site at http://www.deloitte.com/us. Deloitte Touche Tohmatsu is an organization of member firms devoted to excellence in providing professional services and advice. We are focused on client service through a global strategy executed locally in nearly 150 countries. With access to the deep intellectual capital of 120,000 people worldwide, our member firms, including their affiliates, deliver services in four professional areas: audit, tax, financial advisory services and consulting. Our member firms serve more than one-half of the world's largest companies, as well as large national enterprises, public institutions, locally important clients, and successful, fast-growing global growth companies. Deloitte Touche Tohmatsu is a Swiss Verein (association), and, as such, neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. The services described herein are provided by the member firms and not by the Deloitte Touche Tohmatsu Verein. For regulatory and other reasons certain member firms do not provide services in all four professional areas listed above. For further information, please contact: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Raymond W. Cohen, Chief Executive Officer of Cardiac Science, Inc., +1-949-797-3800, . DATASOURCE: Cardiac Science Inc. CONTACT: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Raymond W. Cohen, Chief Executive Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.fast500.com/ Web site: http://www.deloitte.com/us Web site: http://www.cardiacscience.com/

Copyright

Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Cardiac Science Charts.
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Cardiac Science Charts.